• 1. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 2. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

Comprehensive Overview of tert-butyl 3-fluorocyclobutylcarbamate (CAS No. 1284249-30-4)

tert-butyl 3-fluorocyclobutylcarbamate (CAS No. 1284249-30-4) is a fluorinated cyclobutane derivative that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural properties. The compound features a fluorocyclobutyl moiety, which enhances its metabolic stability and bioavailability, making it a valuable intermediate in drug discovery. Researchers are increasingly exploring its applications in the synthesis of novel bioactive molecules, particularly in the development of kinase inhibitors and protease modulators.

The tert-butyl group in tert-butyl 3-fluorocyclobutylcarbamate provides steric protection, improving the compound's stability under various reaction conditions. This characteristic is particularly advantageous in multi-step synthetic routes, where intermediates must withstand harsh conditions. Additionally, the fluorine atom introduces electronegativity, influencing the compound's binding affinity to biological targets. Such properties align with current trends in medicinal chemistry, where fluorinated compounds are prized for their ability to fine-tune pharmacokinetic profiles.

In recent years, the demand for fluorinated building blocks like tert-butyl 3-fluorocyclobutylcarbamate has surged, driven by the growing emphasis on precision medicine and targeted therapies. Pharmaceutical companies are leveraging such compounds to develop next-generation treatments for conditions like cancer, inflammatory diseases, and central nervous system disorders. The compound's versatility also extends to agrochemical applications, where fluorinated derivatives are used to design pesticides with improved efficacy and environmental safety.

From a synthetic perspective, tert-butyl 3-fluorocyclobutylcarbamate is often prepared via carbamate formation reactions, involving the condensation of 3-fluorocyclobutanamine with di-tert-butyl dicarbonate. This method is favored for its high yield and scalability, making the compound accessible for industrial applications. Researchers are also investigating alternative synthetic pathways to optimize efficiency and reduce costs, reflecting the broader shift toward sustainable chemistry practices.

The compound's physicochemical properties, such as its melting point, solubility, and logP value, are critical for its application in drug formulation. Studies have shown that tert-butyl 3-fluorocyclobutylcarbamate exhibits favorable solubility in organic solvents, facilitating its use in liquid-phase reactions. These attributes are frequently discussed in forums and publications focused on advanced synthetic methodologies, highlighting the compound's relevance in contemporary research.

Another area of interest is the role of tert-butyl 3-fluorocyclobutylcarbamate in fragment-based drug design (FBDD). Fragment libraries increasingly incorporate fluorinated scaffolds to explore new chemical space and identify lead compounds with high binding specificity. This approach aligns with the industry's focus on reducing attrition rates in clinical trials by prioritizing molecules with optimized ADME (absorption, distribution, metabolism, and excretion) properties.

Environmental and regulatory considerations also play a role in the compound's adoption. As the chemical industry moves toward greener alternatives, tert-butyl 3-fluorocyclobutylcarbamate is being evaluated for its environmental impact. Researchers are exploring biodegradable derivatives and safer synthetic routes to address concerns about persistent organic pollutants. These efforts resonate with global initiatives like the Green Chemistry Principles, which advocate for sustainable innovation.

In summary, tert-butyl 3-fluorocyclobutylcarbamate (CAS No. 1284249-30-4) represents a versatile and strategically important compound in modern chemistry. Its applications span drug discovery, agrochemical development, and materials science, reflecting the interdisciplinary nature of fluorinated molecules. As research continues to uncover new uses for this compound, its significance in the scientific community is expected to grow, solidifying its position as a cornerstone of innovative chemical design.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)